The Latest Cardiac and Vascular News
SAN FRANCISCO, April 12, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, today released its 2022 Environmental, Social, and Governance (“ESG”) Report highlighting the company’s continued commitment to delivering long-term sustainable growth by operating in a […]
Designation represents progress for patients with suspected Coronary Microvascular Dysfunction as the FDA recognizes disease’s debilitating impacts and the lack of effective non-invasive options for efficient diagnosis MASON, Ohio–(BUSINESS WIRE)–Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted […]
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. released its latest Medical Device Tech Watch, examining care models for cardiac arrhythmia, methods for improving colorectal cancer screening rates and how optimizing surgical tray standardization can reduce costs and improve operational efficiencies. Access Medical Device Tech Watch. “This edition of Tech Watch explores a variety of topics, […]
HOUSTON–(BUSINESS WIRE)–IPS HEART has been granted rare pediatric drug designation by the FDA for GIVI-MPC, a first-in-class stem cell therapeutic to create new skeletal muscle with 100% full length dystrophin and for ISX9-CPC, a first-in-class stem cell therapeutic for creating new functional cardiac muscle for the treatment of patients with Duchenne […]
New feature tackles atrial fibrillation burden, reducing the alerts for patients being treated withanticoagulant medication and highlighting clinically significant events CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ — Implicity, a leader in remote patient monitoring and cardiac data management solutions, introduced a new algorithm designed to reduce alert fatigue in the remote monitoring of […]
WASHINGTON, April 11, 2023 /PRNewswire/ — A first-of-its-kind study has established pediatric reference intervals for two common tests for cardiovascular disease. Published in AACC’s The Journal of Applied Laboratory Medicine, these findings are crucial to advancing diagnosis and treatment of heart conditions in children. View the full study here: https://doi.org/10.1093/jalm/jfad012 Many pediatric hospitals have started […]
VANCOUVER, Wash., April 12, 2023 /PRNewswire/ — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new content hub that provides cardiologists around the world with on-demand access to the latest clinical knowledge. The hub contains original content from five conferences including ACC’s 2022 and […]
WAKEFIELD, Mass., April 12, 2023 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of patient enrollment in the TARGET BP I Pivotal Study evaluating alcohol-mediated renal denervation with the Peregrine System. “We are pleased to announce this significant milestone”, stated Kate Rumrill, […]
Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF) PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030 Strategic decision based upon this significant unmet […]
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies. Mr. Vinyard, who has been with NorthStar since 2021, was […]
